Clinical Trials Logo
  1. Home
  2. Acanthosis Nigricans
  3. NCT06008327

Comparison Of Outcome Of Treatment OF Topical 15%TCA VS Topical 0.05% Tretinoin In Treatment Of Acanthosis Nigricans

Acanthosis Nigricans Clinical Trial

Official title:
Comparison Of The Outcome Of Treatment Of Topical 15% Trichloroacetic Acid Versus Topical 0.05% Tretinoin In The Treatment Of Acanthosis Nigricans

Clinical Trial Summary

Acanthosis nigricans (AN) is a dermatosis with aesthetic implications and is characterized by the focal or diffuse development of a velvety, hyperpigmented cutaneous thickening in intertriginous areas. Trichloroacetic acid (TCA), a superficial chemical exfoliative agent has shown efficacy in treating acanthosis nigricans. Data from this would help in establishing it as a treatment of choice thereby lead to reduction in cost and benefit the patient both financially and psychologically.

Clinical Trial Description

Acanthosis nigricans is common, although exact prevalence depends upon the racial makeup of the population studied. Exact pathogenesis is unknown, elevated insulin concentrations result in direct and indirect activation of IGF-1 receptors on keratinocytes and fibroblasts, leading to proliferation. This hyperpigmentation, which has poorly defined borders, usually occurs in skin fold areas symmetrically, such as the back of the neck, axilla and groin, and may rarely involve oral mucosa. The lesions may be related to a wide range of benign conditions and may occur as a paraneoplastic manifestation of various potentially fatal malignancies. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06008327
Study type Interventional
Source Jinnah Postgraduate Medical Centre
Contact
Status Completed
Phase N/A
Start date August 1, 2022
Completion date June 20, 2023
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05457439 - Sustainable-psycho-nutritional Intervention Program and Its Effects on Health Outcomes and the Environment N/A
Completed NCT01881373 - Children's Healthy Living Community Randomized Trial N/A
Not yet recruiting NCT04893304 - Study of the Effect of Fractional co2 Laser Versus Q Switched:NdYAG Laser in the Treatment of Acanthosis Nigricans N/A
Completed NCT02604095 - Effect of Melatonin on Body Composition, Glucose Metabolism and Lipid Metabolism N/A
Recruiting NCT06331819 - Clinical Association Between Obstructive Sleep Apnea, Facial Pigmentation, and Vasovagal Symptoms.
Not yet recruiting NCT02438020 - Study of Efficacy of Metformin in the Treatment of Acanthosis Nigricans in Children With Obesity Phase 4
Recruiting NCT05529563 - The Effect of Laparoscopic Sleeve Gastrectomy on Insulin Secretion Pattern in Morbidly Obese Patients With Acanthosis Nigricans
Completed NCT00004311 - Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome Phase 2
Completed NCT01125150 - Spectroscopic and Colorimetric Analysis of Acanthosis Nigricans in Patients With Hyperinsulinemia N/A
Recruiting NCT06213987 - The Efficacy Tretinoin Cream in the Treatment of Axillary Hyperpigmentation Associated With Acanthosis Nigricans Phase 3
Recruiting NCT00000112 - Prevalence of Carbohydrate Intolerance in Lean and Obese Children N/A